Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study-Reference-Cited by-同舟云学术

Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study

Published:2021-08 Issue:8 Volume:8 Page:e583-e592
ISSN:2352-3026
Container-title:The Lancet Haematology
language:en
Short-container-title:The Lancet Haematology

Author:

Maneikis Kazimieras,Šablauskas Karolis,Ringelevičiūtė Ugnė,Vaitekėnaitė Vilmantė,Čekauskienė Rita,Kryžauskaitė Lina,Naumovas Daniel,Banys Valdas,Pečeliūnas Valdas,Beinortas Tumas,Griškevičius Laimonas

Publisher

Elsevier BV

Subject

Hematology

Reference25 articles.

1. Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients;Vijenthira;Blood,2020

2. Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set;Chari;Blood,2020

3. High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib;Barbui;Leukemia,2021

4. COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses;Sahin;Nature,2020

5. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine;Polack;N Engl J Med,2020

Cited by 223 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. COVID-19 vaccine immunogenicity and safety surrounding fourth and subsequent vaccine doses in patients with hematologic malignancies;Vaccine;2024-10

2. Antigen-specific T helper cells and cytokine profiles predict intensity and longevity of cellular and humoral responses to SARS-CoV-2 booster vaccination;Frontiers in Immunology;2024-08-29

3. What is the Safety of COVID-19 Vaccines in Immunocompromised Patients? Results from the European “Covid Vaccine Monitor” Active Surveillance Study;Drug Safety;2024-06-22

4. Cellular and humoral immunogenicity against SARS-CoV-2 vaccination or infection is associated with the memory phenotype of T- and B-lymphocytes in adult allogeneic hematopoietic cell transplant recipients;International Journal of Hematology;2024-06-06

5. Serologic Response to Vaccine for COVID-19 in Patients with Hematologic Malignancy: A Prospective Cohort Study;Clinical Lymphoma Myeloma and Leukemia;2024-05